Sie suchten nach: yellow fever (Englisch - Maltesisch)

yellow fever
deni isfar

yellow fever vaccine:
vaċċin kontra d- deni isfar:

detection of yellow fever antigen
is-sejbien ta' l-antiġenu tad-deni isfar

detection of yellow fever nucleic acid.
sejbien ta' l-aċidu nuklejku tad-deni isfar.

if you are given yellow-fever vaccine
jekk tingħata vaċċin kontra d-deni isfar

you have been vaccinated with yellow fever vaccine
ħadt il-vaċċin tad-deni l-isfar

concomitant yellow fever vaccine (see section 4.5).
vaċċin tal-yellow fever fl-istess żmien (ara sezzjoni 4.5).

combination with yellow fever vaccine (see section 4.4)
teħid flimkien ma’ vaċċin tad-deni l-isfar (ara sezzjoni 4.4)

concomitant vaccination with yellow fever vaccine (see section 4.5).
tilqim fl-istess ħin mat-tilqim kontra d-deni isfar (ara sezzjoni 4.5).

if you are breast-feeding. if you will receive yellow fever vaccine.
jekk qed tredda’. jekk ser tirċievi l-vaċċin tad-deni tas-suffejra.

yellow fever vaccine: risk of fatal generalized vaccine-induced disease.
vaċċin tad-deni l-isfar: riskju ta’ mard fatali ġeneralizzat ikkawżat mill-vaċċin.

it must also not be used at the same time as patients are having a yellow fever vaccination.
lanqas ma għandu jintuża fl-istess ħin li l-pazjenti jkunu qed jirċievu vaċċin kontra d-deni l-isfar.

- if you have recently received or are about to receive a vaccine against yellow fever.
- jekk ħadt dan l- aħħar jew dalwaqt ser tieħu tilqima kontra l- yellow fever.

live attenuated vaccines (except yellow fever): risk of systemic, possibly fatal disease.
vaċċini ħajjin attenwati (minbarra d-deni l-isfar): riskju ta’ mard sistematiku, possibbilment fatali.

do not get vaccinated with yellow fever vaccine whilst you are taking xaluprine because it may be fatal.
tiħux il-vaċċin tad-deni l-isfar waqt li qiegħed tieħu xaluprine għaliex jista’ jkun fatali.

yellow fever vaccine: risk of fatal generalised vaccinale disease (see section 4.3).
użu fl- istess zmien kontra- indikat: il- vaċċin tal- yellow fever: riskju ta ’ mard vaċċinali ġeneralizzat li jwassal għall- mewt (ara sezzjoni 4. 3).

it must also not be used together with the vaccine against yellow fever or vaccines containing live viruses or bacteria.
lanqas m’għandu jintuża flimkien mal- vaċċin kontra d-deni tas-suffejra jew vaċċini li fihom virusis jew batterji ħajjin.

concomitant use with yellow fever vaccine and with live virus and bacterial vaccines (see section 4.5).
l-użu konkomitanti mal-vaċċin tad-deni l-isfar u mal-virus ħaj u vaċċini batteriċi (ara sezzjoni 4.5).

you have severe abnormal liver function, you have recently received or are about to receive a vaccine against yellow fever.
b’mod sever, il-fwied tiegħek ma jiffunzjonax tajjeb, dan l-aħħar ingħatajt jew ser tingħata vaċċin kontra l-yellow fever.

it must not be used in women who could become pregnant or who are breastfeeding, or in patients receiving vaccination against yellow fever.
ma għandux jintuża f’nisa li jistgħu ikunu tqal jew li jkunu qegħdin ireddgħu, jew f’pazjenti li qed jirċievu tilqim kontra d-deni l-isfar.